Intelligent Bio Solutions
INBS
10 hedge funds and large institutions have $3.36M invested in Intelligent Bio Solutions in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
1,055% more capital invested
Capital invested by funds: $291K → $3.36M (+$3.07M)
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
100% more funds holding
Funds holding: 5 → 10 (+5)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$2.28M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$392K |
| 3 |
WP
WealthShield Partners
Cary,
North Carolina
|
+$191K |
| 4 |
VF
Virtu Financial
New York
|
+$95.7K |
| 5 |
Goldman Sachs
New York
|
+$76.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$47.8K |
| 2 |
BlackRock
New York
|
-$9.57K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9K |
| 4 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$6K |
INBS Hedge Fund Activity: Q2 2021 in Review
10 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q2 2021, worth a combined $3.36M — up 1,055% from $291K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new INBS positions and 2 closed out — a net gain of 5 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $2.28M. The largest seller was Citadel Advisors, cutting an estimated $47.8K.
- 10 institutional investors held Intelligent Bio Solutions (INBS) as of Q2 2021, up from 5 in Q1 2021.
- Funds reported $3.36M of Intelligent Bio Solutions stock for Q2 2021, up 1,055% quarter-over-quarter.
- 7 funds opened new Intelligent Bio Solutions positions in Q2 2021 and 2 closed out, a net change of +5 holders.
- The largest Intelligent Bio Solutions buyer in Q2 2021 was Anson Funds Management, an estimated $2.28M added.
- The largest Intelligent Bio Solutions seller in Q2 2021 was Citadel Advisors, an estimated $47.8K sold.
Based on aggregated 13F filings for Q2 2021.